Here we go! Balzar conf call Nov 6th

Discussion in 'Sanofi' started by anonymous, Oct 16, 2017 at 10:15 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Right on cue with the November change in the fall colors is the annual Sanofi Thanksgiving Early December Christmas Gift. Your walking papers! Joe will layout the timeline but remember to finish strong and stay focused. Good luck to all this year. It wouldn't be December unless this happened.
     

  2. anonymous

    anonymous Guest

     
  3. anonymous

    anonymous Guest

    Not true.

    The sales force is going to be pleasantly surprised. That's all I'm gonna say. Sanofi home office is surprisingly excited ever since the Praluent news. Keep your heads up, it's gonna be a great 2017-2018. Could get dicey after that
     
  4. anonymous

    anonymous Guest

    Yeah, when Balzer addresses the sales force (or when the fat lady sings) we all know what is about to happen----this shit is about to get up close and personal. Never mind his analogies about the slow elevator ride down, stopping at every floor; this bitch is about to free fall to the basement and land HARD!! Get ready all, things are about to get very interesting---buckle up and be prepared for big Joe to start swinging his axe--it ain't gonna be a pretty picture come the end of November----another bloody Sanofi November.
     
  5. anonymous

    anonymous Guest

    Nah, this is just another ballsack slap to 'motivate' greater effort in spite of the impossibility of meeting your sales goals, which of course have not been released 2 weeks into the quarter. Gotta make sure they dont have to pay out a fucking dime. Only way to be sure is see actual sales for week 1 and add 40%.... the real cuts come in december after the SERIO headcount
     
  6. anonymous

    anonymous Guest

    You mean the news that Praluent sales suck just as badly as Repatha? Sanofi can't move Lantus in the face of a cheap biosimilar, but our savior is going to a drug that costs $14K, the profits on which we have to split with Regeneron?

    Can I get a dime bag of whatever home office is smoking?
     
  7. anonymous

    anonymous Guest

    Joe has no news it will be the new head of DCV who will make announcement. Balls is just a middle man
     
  8. anonymous

    anonymous Guest

    So will this be the day we get word of the restructure and downsizing that 50% of us fully support and the other 50% are denying will ever happen? Inquiring minds want to know!
     
  9. anonymous

    anonymous Guest

    Like the original poster said it wouldn't be Sanofi unless there was massacre in December. Diabetes getting throttled again. If Praluent is to survive it will depend on the outcomes data in March. Also the price will have to drop and managed care plans won't budge until this happens. Setting impossible goals in Diabetes and Cardiovascular and sticking it to reps with impossible quota to insure low payout has been the norm. Look at goals set in Diabetes !!!! Impossible !!' Look at goals for Praluent and Mulcrap!!! This footprint isn't working and prices and managed care control everything. This company is in deep trouble. Sanofi needs a complete management overhaul. Every RBL and above should be gone. Executive board is an embarrassment. The same clowns that gave the green light to hire Chris (schlong) Kaplan.
     
  10. anonymous

    anonymous Guest

    This December is about cutting costs which need to be done for short term. DCV isn't making money to warrant headcount . Still many wasteful jobs- hospital, LTC, Regional Acct, training ,CEM's . Also ABL's will have restructure to allocate correct number of reps that will report to them. No more 3-4 reps per ABL. Also RBL's will get larger regions. This was supposed to be done last year but Kaplan took care of some people. He's gone so it's open season.
     
  11. anonymous

    anonymous Guest

    Does anyone Inside 55 know if this will be discussed or at least eluded to on the Nov. 6th call?
     
  12. anonymous

    anonymous Guest

    Will depend on next few weeks.
     
  13. anonymous

    anonymous Guest

    Alluded. The correct word is alluded.

    Although they always have done a great job in eluding many things. Making good decisions is one of them.
     
  14. anonymous

    anonymous Guest

    Yes we have all gathered that managers, ltc, hospital reps will be cut or reassigned. What about PC reps? No one seems to know anything where they are concerned.
     
  15. anonymous

    anonymous Guest

    PC1 are in danger. If they haven't been working on plan B that's ashame. You forgot Regional Acct people, CEM's, LTC and anything associated with Hospital.
     
  16. anonymous

    anonymous Guest

    These posts are priceless. You lack-wits forgot how to sell years ago because you had ZERO competition. You had 10+ years of Lantus. Who did you actually need to sell against? NPH? Levemir? Now that you have to competitively differentiate, you want to blame everyone around you for your inability to sell these products. Welcome to MODERN PHARMA. Everyone has a ME TOO drug and it takes a SALES person to sell in this market, not a donut delivery boy/girl armed only with a managed care message.

    Novo’s doesn’t have better products, they have better reps. They competitively sell and call people out if they don’t write. Yes, Sanofi management is inept, but you idiots think that leading with a copay card is a solid sales call. Then you blame your idiotic management for your inability to sell?

    HAHAHAHAHAHAHAHAHAHAHA...enjoying watching you all slide to the bottom of the icy Atlantic
     
  17. anonymous

    anonymous Guest

    There is always a need for experience and knowledge rooted in traditions, but it is not a spiritual given that these are the places where peace, union, and spiritual awareness are found.
     
  18. anonymous

    anonymous Guest

    LOL, then hire Novo reps. Oh shit we did and they suck too
     
  19. anonymous

    anonymous Guest

    LMFAO, a drug who thinks he/she is in sales regardless of the drug or company
     
  20. anonymous

    anonymous Guest

    SPOKEN BY A TRUE USED CAR SALESMAN. YOUR TYPE IS THE REASON WHY HEALTHCARE SYSTEMS HATE PHARMA. NOVO HAS BETTER DATA and BETTER COVERAGE. ANY MORON CAN SEE THE CORRELATION!! GET THAT CONCEPT BUDDY?? NOW... GET YOUR HEAD OUT OF YOUR OWN ASS AND FIND US SOME REAL DATA THAT IS INCLUDED IN THE PI AND WIN US BACK SOME PLANS AND WE'LL HAVE SOMETHING TO SELL. MODERN PHARMA (AS YOU CALL IT) IS ABOUT SHOWING TRUE WORTH AND DATA ALONG WITH SAVINGS. GONE ARE THE DAYS WHERE WINING & DINING BUY RX'S. NO MORE DINE & DASHES. 'SIMILAR' EFFICACY ISN'T WHAT IM TALKING ABOUT. IM TALKING TRUE EFFICACY THAT MATTERS FOR THE MONEY. AT LEAST GIVE US CV OUTCOMES FOR GOD'S SAKE. OVERALL THOUGH..... I KNOW YOU HATE THIS BUT IT'S TRUE...... MC COVERAGE MAKES THE BIGGEST DIFFERENCE WHEN WE'RE TALKING ME-TOOS. PERIOD. COPAY CARDS MAY NOT MAKE A DIFFERENCE BUT MC PLANS DO! ALSO....... WHAT THE HELL ARE ALL THESE MIDDLE MANAGERS DOING??? THEY'RE SURE AS HELL NOT DOING ANYTHING THAT HELPS THE BOTTOM LINE. I'M SURE YOU'RE ONE OF THEM. SMH........... IF WE ALL SUCK SO BAD THEN LAY US OFF AND REBUILD! SERIOUSLY IF WE'RE SO BAD AT WHAT WE DO THEN CUT US LOOSE AND MOVE ON WITH BETTER SALES PEOPLE. THEY'D HAVE LESS VACATION AND LESS BENNIES. UNFORTUNATELY FOR YOU THOUGH WE'RE THE WORST PAID IN THE INDUSTRY NEXT TO CONTRACT SO YOU MAY HAVE A PROBLEM THERE.